Efficacy and safety of tabelecleucel in patients with EpsteinBarr Virus-associated leiomyosarcomas (EBV(+)LMS) Meeting Abstract

  

Authors:	Kurlander, L. S.; Srinivasan, A.; Ghobadi, A.; Suser, S.; Doubrovina, E.; Boulad, F.; Mascarenhas, L.; Laquaglia, M.; Price, A.; Behr, G.; Shulkin, B.; Sudhindra, A.; Wei, Y.; Hiremath, M.; Navarro, W.; O'Reilly, R.; Prockop, S.
Abstract Title:	Efficacy and safety of tabelecleucel in patients with EpsteinBarr Virus-associated leiomyosarcomas (EBV(+)LMS)
Meeting Title:	ESMO Immuno-Oncology Congress 2018
Journal Title:	Annals of Oncology
Volume:	29
Issue:	Suppl. 10
Meeting Dates:	2018 Dec 13-16
Meeting Location:	Geneva, Switzerland
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2018-12-01
Start Page:	mdy485.003
Language:	English
ACCESSION:	WOS:000459294800041
PROVIDER:	wos
DOI:	10.1093/annonc/mdy485.003
Notes:	Meeting Abstract: 34O -- Appears on page x12 of the abstract book -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/145117